EVA

Regimen

Etoposide 200 mg/m2 IV days 1-5
Vincristine 2 mg/m2 IV on day 1
Doxorubicin 50 mg/m2 IV on day 2

Repeat cycle every 28 days

References

Radford JA et al. Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease. J Clin Oncol. 1995 Sep;13(9):2379-85

Johnson PW et al. Comparison of ABVD and Alternating or Hybrid Multidrug Regimens for the Treatment of Advanced Hodgkin's Lymphoma: Results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519). J Clin Oncol. 2005 Dec 20;23(36):9208-18. Epub 2005 Nov 28.